Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chickenpox immunisation in New Zealand

M Tobias1, S Reid, D Lennon

  • 1Public Health Group, Ministry of Health, Wellington.

The New Zealand Medical Journal
|September 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic test accuracy of each of the four IDEA ultrasound steps in predicting presence of deep endometriosis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

The Impact of Targeted Informal Information Days on Early-Career Doctor's Interest in Surgery.

Irish medical journal·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Association of fetal cerebral growth and sulcal development with 2-year neurodevelopmental outcome in children with prenatally diagnosed mild-to-moderate isolated ventriculomegaly.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

AAV-shDUX4 provides short-term benefits but limited long-term efficacy in a DUX4 mouse model of FSHD.

Molecular therapy. Methods & clinical development·2025

The varicella vaccine Varilrix is approved for healthy children in New Zealand but not for immunocompromised individuals. Further data is needed to assess its use in outbreak control and routine childhood immunization.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • The Ministry of Health Working Party reviewed varicella vaccine use in New Zealand in 1996-1997.
  • Varicella vaccine is effective in preventing chickenpox.

Purpose of the Study:

  • To evaluate the appropriateness of varicella vaccine use in New Zealand.
  • To determine recommendations for Varilrix vaccine distribution and administration.

Main Methods:

  • Review of data and discussions from a Ministry of Health Working Party and workshop.
  • Assessment of Varilrix vaccine's suitability for different population groups.

Main Results:

  • Introduction of varicella vaccine into the routine childhood immunization schedule was not supported.

Related Experiment Videos

  • Varilrix vaccine use was supported for healthy children aged nine months to 13 years.
  • Varilrix vaccine use was not supported for immunocompromised individuals or adults.

    • Conclusions:

    • Varilrix is approved for healthy children in New Zealand, but not for immunocompromised individuals or adults.
    • Vaccination on a named patient basis may be considered for specific groups like children with deteriorating renal function and susceptible healthcare workers.
    • Enhanced surveillance of chickenpox and zoster, along with monitoring adverse reactions to Varilrix, is required. Insufficient data exists to support Varilrix use in outbreak control.